Implementing Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations

Washington, DC
Ask a Question
Duration:  2 days
Time: 8:30 a.m. - 4:00 p.m.

This course will provide detailed guidance for application and implementation of quality risk management principles throughout the product lifecycle, with emphasis on quality risk management application during commercial manufacturing, and integrating quality risk management into the pharmaceutical quality system. The course will build on the content and principles of ICH Q9, Quality Risk Management. The application of quality risk management will be discussed from a life-cycle approach, from pharmaceutical development to technology transfer, commercial manufacturing, product discontinuation, and will include materials management and contract services. Case study examples of the application of quality risk management will be given for different types of manufacturing operations such as biotech API manufacturing, drug product manufacturing, packaging and labeling.

Who Should Attend

Managers and supervisors in manufacturing, technology transfer, quality assurance and regulatory affairs will benefit from this course.

Prerequisites

A basic understanding of risk management principles will be helpful to participants in this course.

More information coming soon.

Day 1

Upon completion of this course, you will be able to:

  • Describe when, where, and how to apply quality risk management throughout the product lifecycle with emphasis on commercial manufacturing
  • Plan quality risk management activities
  • Execute risk assessments and develop an overall strategy for the use of different risk assessment tools
  • Establish a quality risk management policy and implement the essential elements for risk management in your organization
  • Apply the principles learned to conduct risk management activities for a variety of product-related and operational decisions in your job

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

Renaissance Washington DC Downtown Hotel

999 9th St NW
Washington, DC ,

Jeffrey Hartman, Senior Consultant, Concordia ValSource

Amanda McFarland, Consultant, ValSource

Amanda Bishop McFarland, M.S. is a Quality Risk Management and Microbiology Consultant with Concordia Valsource, LLC. She specializes in the creation and implementation of Risk Management programs and in developing risk-based strategies for use in Quality Systems including Quality Control, Validation, and Change Management. In 2015, Amanda presented at the Institute of Validation Technology’s Quality Risk Management Series and IVT’s Microbiology Week. She has a Bachelors of Science (Entomology) and a Masters of Science in Mycology, both from the University of Florida. Amanda is an active member of the Parenteral Drug Association (PDA) and a faculty member of the PDA’s Quality Risk Management and Risk-Based Qualification of Sterile Drug Product Manufacturing Systems training series.